Randomized phase II trial of the cyclin-dependent kinase inhibitor dinaciclib (MK-7965) versus capecitabine in patients with advanced breast cancer (Q34396031)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized phase II trial of the cyclin-dependent kinase inhibitor dinaciclib (MK-7965) versus capecitabine in patients with advanced breast cancer |
scientific article |
Statements
1 reference
Randomized phase II trial of the cyclin-dependent kinase inhibitor dinaciclib (MK-7965) versus capecitabine in patients with advanced breast cancer (English)
1 reference
Monica M Mita
1 reference
Anil A Joy
1 reference
Alain Mita
1 reference
Kamalesh Sankhala
1 reference
Ying-Ming Jou
1 reference
Da Zhang
1 reference
Paul Statkevich
1 reference
Yali Zhu
1 reference
Siu-Long Yao
1 reference
Karen Small
1 reference
Rajat Bannerji
1 reference
Charles L Shapiro
1 reference
26 October 2013
1 reference
1 reference
Identifiers
1 reference